OKYO Pharma OKYO
NASDAQ OKYO
$1.40 +0.12 (+9.38%)
As of: Nov 10, 2026 · 2:42 PM EST

OKYO Pharma (OKYO) Receivables - Net (2021 - 2026)

Updated

Analysis

OKYO Pharma (OKYO) Receivables - Net (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 OKYO Pharma 1.37 Bn 1.34 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 375,749.00
Mar 31, 2025 242,342.00
Mar 31, 2024 151,938.00
Mar 31, 2023 592,195.00
Mar 31, 2022 812,956.00
Mar 31, 2021 43,370.00
API Access

OKYO Pharma Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=OKYO&period=max&api_key=YOUR_API_KEY